MedTrace Logo

Evaluation of Ketamine and Multi-modal Analgesics

NCT02815111 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2019-07-31

No results posted yet for this study

Summary

The purpose of this research study is to see if pain can be better controlled with fewer side effects. The new drug regimen will study several different medicines that have different ways of treating pain.

Conditions

Interventions

DRUG

Ketamine

Receive an analgesic regimen that involves Ketamine infusions

DRUG

Lidocaine

Receive an analgesic regimen that involves Lidocaine infusions

DRUG

Acetaminophen

May be administered Acetaminophen rectally, by mouth, or intravenously in patients not suitable for either of the other methods of administration

DRUG

Neurontin

May be given Neurontin by mouth as an approved medication for pain control

Sponsors & Collaborators

  • University of Florida

    lead OTHER

Principal Investigators

  • Sean Kiley, M.D. · University of Florida

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-07-31
Primary Completion
2018-01-31
Completion
2018-07-31

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02815111 on ClinicalTrials.gov